BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salatzki J, Foryst-Ludwig A, Bentele K, Blumrich A, Smeir E, Ban Z, Brix S, Grune J, Beyhoff N, Klopfleisch R, Dunst S, Surma MA, Klose C, Rothe M, Heinzel FR, Krannich A, Kershaw EE, Beule D, Schulze PC, Marx N, Kintscher U. Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure. PLoS Genet 2018;14:e1007171. [PMID: 29320510 DOI: 10.1371/journal.pgen.1007171] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Janovska P, Melenovsky V, Svobodova M, Havlenova T, Kratochvilova H, Haluzik M, Hoskova E, Pelikanova T, Kautzner J, Monzo L, Jurcova I, Adamcova K, Lenkova L, Buresova J, Rossmeisl M, Kuda O, Cajka T, Kopecky J. Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin. J Cachexia Sarcopenia Muscle 2020;11:1614-27. [PMID: 33084249 DOI: 10.1002/jcsm.12631] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ritter D, Goeritzer M, Thiele A, Blumrich A, Beyhoff N, Luettges K, Smeir E, Kasch J, Grune J, Müller OJ, Klopfleisch R, Jaeger C, Foryst-Ludwig A, Kintscher U. Liver X Receptor Agonist AZ876 Induces Beneficial Endogenous Cardiac Lipid Reprogramming and Protects Against Isoproterenol-Induced Cardiac Damage. J Am Heart Assoc 2021;10:e019473. [PMID: 34227403 DOI: 10.1161/JAHA.120.019473] [Reference Citation Analysis]
3 Parajuli N, Takahara S, Matsumura N, Kim TT, Ferdaoussi M, Migglautsch AK, Zechner R, Breinbauer R, Kershaw EE, Dyck JRB. Atglistatin ameliorates functional decline in heart failure via adipocyte-specific inhibition of adipose triglyceride lipase. Am J Physiol Heart Circ Physiol 2018;315:H879-84. [PMID: 29932770 DOI: 10.1152/ajpheart.00308.2018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
4 Reed D, Kumar D, Kumar S, Raina K, Punia R, Kant R, Saba L, Cruickshank-quinn C, Tabakoff B, Reisdorph N, Edwards MG, Wempe M, Agarwal C, Agarwal R. Transcriptome and metabolome changes induced by bitter melon (Momordica charantia)- intake in a high-fat diet induced obesity model. Journal of Traditional and Complementary Medicine 2021. [DOI: 10.1016/j.jtcme.2021.08.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Henderson GC. Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease. Nutrients 2021;13:2590. [PMID: 34444750 DOI: 10.3390/nu13082590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Czaja-Stolc S, Potrykus M, Stankiewicz M, Kaska Ł, Małgorzewicz S. Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease. Nutrients 2022;14:1457. [PMID: 35406070 DOI: 10.3390/nu14071457] [Reference Citation Analysis]
7 Lapinskas T, Kelle S, Grune J, Foryst-Ludwig A, Meyborg H, Jeuthe S, Wellnhofer E, Elsanhoury A, Pieske B, Gebker R, Kintscher U, Stawowy P. Serelaxin Improves Regional Myocardial Function in Experimental Heart Failure: An In Vivo Cardiac Magnetic Resonance Study. J Am Heart Assoc 2020;9:e013702. [PMID: 32000566 DOI: 10.1161/JAHA.119.013702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Smeir E, Kintscher U, Foryst-Ludwig A. Adipose tissue-heart crosstalk as a novel target for treatment of cardiometabolic diseases. Curr Opin Pharmacol 2021;60:249-54. [PMID: 34482212 DOI: 10.1016/j.coph.2021.07.017] [Reference Citation Analysis]
9 Oikonomou EK, Antoniades C. The role of adipose tissue in cardiovascular health and disease. Nat Rev Cardiol 2019;16:83-99. [PMID: 30287946 DOI: 10.1038/s41569-018-0097-6] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 55.0] [Reference Citation Analysis]
10 Bottermann K, Granade ME, Oenarto V, Fischer JW, Harris TE. Atglistatin Pretreatment Preserves Remote Myocardium Function Following Myocardial Infarction. J Cardiovasc Pharmacol Ther 2021;26:289-97. [PMID: 33150796 DOI: 10.1177/1074248420971113] [Reference Citation Analysis]
11 Takahara S, Ferdaoussi M, Srnic N, Maayah ZH, Soni S, Migglautsch AK, Breinbauer R, Kershaw EE, Dyck JRB. Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation. Am J Physiol Heart Circ Physiol 2021;320:H432-46. [PMID: 33185110 DOI: 10.1152/ajpheart.00737.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Blumrich A, Vogler G, Dresen S, Diop SB, Jaeger C, Leberer S, Grune J, Wirth EK, Hoeft B, Renko K, Foryst-Ludwig A, Spranger J, Sigrist S, Bodmer R, Kintscher U. Fat-body brummer lipase determines survival and cardiac function during starvation in Drosophila melanogaster. iScience 2021;24:102288. [PMID: 33889813 DOI: 10.1016/j.isci.2021.102288] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhao H, Zhang H, Wang Y, Zhao T, Yan M, Dong X, Wang Q, Li J, Ma L, Li P. Association between PNPLA2 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in a Chinese Han Population with Type 2 Diabetes. J Diabetes Res 2020;2020:5424701. [PMID: 32685558 DOI: 10.1155/2020/5424701] [Reference Citation Analysis]
14 Han X, Zhang YL, Lin QY, Li HH, Guo SB. ATGL deficiency aggravates pressure overload-triggered myocardial hypertrophic remodeling associated with the proteasome-PTEN-mTOR-autophagy pathway. Cell Biol Toxicol 2022. [PMID: 35218467 DOI: 10.1007/s10565-022-09699-0] [Reference Citation Analysis]
15 Santos D, Carvalho E. Adipose-related microRNAs as modulators of the cardiovascular system: the role of epicardial adipose tissue. J Physiol 2021. [PMID: 34455587 DOI: 10.1113/JP280917] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Grabner GF, Guttenberger N, Mayer N, Migglautsch-Sulzer AK, Lembacher-Fadum C, Fawzy N, Bulfon D, Hofer P, Züllig T, Hartig L, Kulminskaya N, Chalhoub G, Schratter M, Radner FPW, Preiss-Landl K, Masser S, Lass A, Zechner R, Gruber K, Oberer M, Breinbauer R, Zimmermann R. Small-Molecule Inhibitors Targeting Lipolysis in Human Adipocytes. J Am Chem Soc 2022. [PMID: 35362954 DOI: 10.1021/jacs.1c10836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Schreiber R, Xie H, Schweiger M. Of mice and men: The physiological role of adipose triglyceride lipase (ATGL). Biochim Biophys Acta Mol Cell Biol Lipids 2019;1864:880-99. [PMID: 30367950 DOI: 10.1016/j.bbalip.2018.10.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
18 Choi Y, Shin H, Tang Z, Yeh Y, Ma Y, Kadegowda AKG, Wang H, Jiang L, Arya RK, Chen L, Xue B, Shi H, Gavrilova O, Yu L. Adipose Lipolysis Regulates Cardiac Glucose Uptake and Function in Mice under Cold Stress. Int J Mol Sci 2021;22:13361. [PMID: 34948160 DOI: 10.3390/ijms222413361] [Reference Citation Analysis]
19 Thiele A, Luettges K, Ritter D, Beyhoff N, Smeir E, Grune J, Steinhoff JS, Schupp M, Klopfleisch R, Rothe M, Wilck N, Bartolomaeus H, Migglautsch AK, Breinbauer R, Kershaw EE, Grabner GF, Zechner R, Kintscher U, Foryst-Ludwig A. Pharmacological inhibition of adipose tissue Adipose Triglyceride Lipase (ATGL) by Atglistatin prevents catecholamine-induced myocardial damage. Cardiovasc Res 2021:cvab182. [PMID: 34061169 DOI: 10.1093/cvr/cvab182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Nguyen TD, Schulze PC. Lipid in the midst of metabolic remodeling - Therapeutic implications for the failing heart. Adv Drug Deliv Rev 2020;159:120-32. [PMID: 32791076 DOI: 10.1016/j.addr.2020.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
21 Nadaud S, Flamant M, Le Goff W, Balse E, Pavoine C. Transcriptomic and Lipidomic Mapping of Macrophages in the Hub of Chronic Beta-Adrenergic-Stimulation Unravels Hypertrophy-, Proliferation-, and Lipid Metabolism-Related Genes as Novel Potential Markers of Early Hypertrophy or Heart Failure. Biomedicines 2022;10:221. [DOI: 10.3390/biomedicines10020221] [Reference Citation Analysis]
22 Kintscher U, Foryst-Ludwig A, Haemmerle G, Zechner R. The Role of Adipose Triglyceride Lipase and Cytosolic Lipolysis in Cardiac Function and Heart Failure. Cell Rep Med 2020;1:100001. [PMID: 33205054 DOI: 10.1016/j.xcrm.2020.100001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Smeir E, Leberer S, Blumrich A, Vogler G, Vasiliades A, Dresen S, Jaeger C, Gloaguen Y, Klose C, Beule D, Schulze PC, Bodmer R, Foryst-Ludwig A, Kintscher U. Depletion of cardiac cardiolipin synthase alters systolic and diastolic function. iScience 2021;24:103314. [PMID: 34805785 DOI: 10.1016/j.isci.2021.103314] [Reference Citation Analysis]
24 Betz IR, Qaiyumi SJ, Goeritzer M, Thiele A, Brix S, Beyhoff N, Grune J, Klopfleisch R, Greulich F, Uhlenhaut NH, Kintscher U, Foryst-Ludwig A. Cardioprotective Effects of Palmitoleic Acid (C16:1n7) in a Mouse Model of Catecholamine-Induced Cardiac Damage Are Mediated by PPAR Activation. Int J Mol Sci 2021;22:12695. [PMID: 34884498 DOI: 10.3390/ijms222312695] [Reference Citation Analysis]